Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure

Journal of Pediatric Gastroenterology and Nutrition

Volumn 44, Issue 2, 2007, Pages 224-227

  Aw, Marion M ^a   Mitry, Ragai R ^a   Hughes, Robin D ^a   Dhawan, Anil ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Hepatocyte growth factor; Liver failure; Regeneration; Vascular endothelial growth factor

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; SCATTER FACTOR; VASCULOTROPIN;

ADOLESCENT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CHEMISTRY; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DELTA AGENT HEPATITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS E; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER FAILURE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; STATISTICAL SIGNIFICANCE; TOXIC HEPATITIS; VIRUS HEPATITIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; INFANT; LIVER FAILURE, ACUTE; MALE; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

NON-A, NON-B HEPATITIS VIRUS;

EID: 33846642671     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31802c686b     Document Type: Article

References (17)

1. Gonwa TA, Mai ML, Melton LLB, et al. End-stage renal disease after orthotopic liver transplantation using calcineurin-based immunotherapy. Risk of development and treatment. Transplantation 2001;72:1934-9.
2. Jain AB, Yee LD, Nalesnick MA, et al. Comparative incidence of denovo non-lymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998;66:1193-200.
3. O'Grady J, Alexander G, Hayllar K, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-45.
4. Fausto N, Laird AD, Webber EM. Liver regeneration. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995;9:1527-36.
5. Fausto N. Liver regeneration. J Hepatol 2000;32 (Suppl 1):19-31.
6. Mochida S, Ishikawa K, Inao M, et al. Increased expression of vascular endothelial growth factor and its receptors, flt-1 and KDR/ flk-1, in regenerating rat liver. Biochem Biophys Res Commun 1996;226 (1):176-9.
7. Ishikawa K, Mochida S, Mashiba S, et al. Expression of vascular endothelial growth factor in nonparenchymal as well as parenchymal cells in rat liver necrosis. Biochem Biophy Res Commun 1999;254:587-93.
8. Assy N, Spira G, Paizi M, et al. Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats. J Hepatol 1999;30:911-5.
9. Shimizu H, Miyazaki M, Wakabayashi Y, et al. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol 2001;34:683-9.
10. Granot E, Boros P, Miller CM. Differential effect of hepatocyte growth factor and tumor growth factor-β on early release of vascular endothelial growth factor from HepG2 cells: possible implications in post-transplant liver regeneration. Transpl Proc 2001;31:2926-8.
11. Taniguchi E, Sakisaka S, Matsuo K, et al. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem 2001;49:121-9.
12. LeCouter J, Moritz DR, Li B, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003;299:890-3.
13. Bhaduri BR, Mieli-Vergani G. Fulminant hepatic failure: pediatric aspects. Semin Liver Dis 1996;16:349-55.
14. Hughes RD, Zhang L, Tsubouchi H, et al. Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure. J Hepatol 1994;20:106-11.
15. Akiyoshi F, Sata M, Suzuki H, et al. Serum vascular endothelial growth factor levels in various liver diseases. Dig Dis Sci 1998;43: 41-5.
16. Auth MK, Kim HS, Beste M, et al. Removal of metabolites, cytokines and hepatic growth factors by extra-corporeal liver support in children. J Pediatric Gastroenterol Nutr 2005;40:54-9.
17. Marino G, Piazzese E, Gruttadauria S, et al. Innovative use of the vascular endothelial growth factor in an experimental model of acute liver failure. G Chir 2004;25:61-4.